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Little is known about the associations of eating a late-evening meal (ELM), a putative unhealthy eating behavior,
with low serum amylase, other eating behaviors, and cardiometabolic risk factors. Therefore, we investigated
whether ELM before bedtime was associated with low serum amylase or other clinical factors in 2,426 asymptomatic
adults aged 20–80 years. Multivariate logistic regression analysis showed that ELM was significantly associated with low
serum amylase (<60 IU/l), overweight, smoking, daily alcohol consumption, skipping breakfast, and rapid eating, but
not with abnormal glucose metabolism. In conclusion, ELM may be independently associated with low serum amylase
and common unhealthy behaviors.
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Although eating a late-evening meal (ELM) is likely to
be an unhealthy behavior that may cause postprandial
hyperglycemia and decrease the metabolic rate [1-3], the
physiological and clinical relevance of ELM is poorly
understood. In our previous studies, low serum amylase
was associated with obesity, type 2 diabetes, metabolic
syndrome, and non-alcoholic fatty liver disease [4,5].
Therefore, we investigated whether ELM was associated
with low serum amylase and other unhealthy conditions
or eating behaviors in 2,426 asymptomatic adults.
The subjects were asymptomatic adults aged 20–80
years who lived in Saitama, Japan, and underwent tho-
rough medical checkups at Social Insurance Omiya
General Hospital, Saitama, Japan. This study was con-
ducted using data collected between 2009 and 2010.
The protocol was approved by the Ethics Committee
of Josai University, and informed consent was obtained
from all participants. Subjects with suspected acute pan-
creatitis (serum amylase >200 IU/l), very low serum amy-
lase (<30 IU/l), or suspected renal failure were excluded
from the study. Subjects completed a questionnaire, which* Correspondence: keinaka@josai.ac.jp
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reproduction in any medium, provided the orwas developed by the Japanese Ministry of Health, Labour
and Welfare in 2007 to prevent metabolic syndrome and
cardiovascular diseases [6]. Suspected ELM, skipping
breakfast, and rapid eating were determined using the
questions, “Do you eat a late-evening meal within 2 hour
before bedtime at least three times per week?”, “Do you
skip breakfast at least three times per week?”, and “Do you
think your meal-eating speed is usually rapid compared
with other people’s?”, respectively, for which the available
responses were yes or no.
Anthropometric and laboratory tests were conducted
after an overnight fast. Serum parameters were measured
using an autoanalyzer (Hitachi, Tokyo, Japan). Serum
amylase levels were measured using an enzymatic method
(L-type Amylase; Wako, Tokyo, Japan) with a normal
range of 41–112 IU/l. We defined low serum amylase
as <60 IU/l, as previously described [5]. HbA1c was
converted to National Glycohemoglobin Standardization
Program levels [7].
Table 1 shows the clinical characteristics of the sub-
jects. Overall, subjects who reported ELM were younger,
which likely affected the less proportion of dyslipidemia,
more frequently males, smokers, and daily alcohol con-
sumers, had a higher body mass index, and frequently
reported unhealthy eating behaviors. Multivariate logistic
regression analysis showed that ELM was independentlyLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.




Men, (%) 56.8 82.6 < 0.0001
Age 56.0 ± 11.8 48.8 ± 10.7 < 0.0001
BMI (kg/m2) 22.9 ± 3.1 24.0 ± 3.4 < 0.0001
Systolic blood pressure (mmHg) 122 ± 18.8 120 ± 18.9 0.18
Diastolic blood pressure (mmHg) 75.4 ± 12.5 76.1 ± 13.1 0.16
Triglyceride (mg/dl) 91 (66–133) 101 (71–144) < 0.0001
HDL-cholesterol (mg/dl) 62.5 ± 14.8 57.9 ± 14.6 < 0.0001
FPG (mg/dl) 101 ± 18.5 102 ± 17.2 0.30
HbA1c (%, NGSP) 5.7 ± 0.6 5.6 ± 0.6 0.0005
eGFR (ml/min/1.73 m2) 75.2 ± 14.0 78.3 ± 13.1 < 0.0001
Serum amylase (IU/l) 76.2 ± 23.8 69.2 ± 22.0 < 0.0001
Medications for
Hypertension, n (%) 293 (18.1) 118 (14.7) 0.03
Diabetes, n (%) 60 (3.7) 21 (2.6) 0.16
Dyslipidemia, n (%) 205 (12.6) 47 (5.8) < 0.0001
Past history
Heart disease, n (%) 29 (1.8) 12 (1.5) 0.59
Stroke, n (%) 65 (4.0) 20 (2.5) 0.05
Current smoking, n (%) 318 (19.6) 311 (38.6) < 0.0001
Daily alcohol consumption,
n (%)
419 (25.8) 339 (42.1) < 0.0001
Regular exercise, n (%) 605 (37.3) 166 (20.6) < 0.0001
Self-reported skipping breakfast,
n (%)
159 (9.8) 232 (28.8) < 0.0001
Self-reported rapid eating, n (%) 406 (25.0) 313 (38.9) < 0.0001
Data are expressed as means ± SD, median (interquartile range), or n (%).
Differences in continuous and categorical variables between the two groups
were examined using t-tests and χ2-tests, respectively, except for triglyceride,
which was compared using the Mann–Whitney test.
eGFR was calculated as previously described [5].
BMI, body mass index; eGFR, estimated glomerular filtration rate; ELM, eating a
late-evening meal; FPG, fasting plasma glucose; HbA1c, hemoglobin A1c; HDL,
high-density lipoprotein; NSGP, National Glycohemoglobin
Standardization Program.
Table 2 Odds ratios of low serum amylase and other
clinical variables for ELM
OR (95% CI) P value
Low serum amylase
Model 1 1.86 (1.55–2.23) <0.0001
Model 2 1.47 (1.20–1.79) 0.0002
Model 3 1.41 (1.16–1.73) 0.0008
Model 4 1.33 (1.08–1.63) 0.008
Men
Model 1 3.61 (2.94–4.44) <0.0001
Model 4 2.28 (1.80–2.90) <0.0001
Current smoking
Model 1 2.58 (2.14–3.11) <0.0001
Model 4 1.28 (1.03–1.59) 0.03
Daily alcohol drinking
Model 1 2.48 (2.01–3.05) <0.0001
Model 4 1.83 (1.43–2.34) <0.0001
Regular exercise
Model 1 0.44 (0.36–0.53) <0.0001
Model 4 0.66 (0.53–0.83) 0.0004
Overweight (BMI ≥25.0 kg/m2)
Model 1 1.89 (1.57–2.29) <0.0001
Model 4 1.38 (1.11–1.71) 0.004
Self–reported breakfast skipping
Model 1 3.72 (2.98–4.66) <0.0001
Model 4 2.18 (1.70–2.80) <0.0001
Self–reported rapid eating
Model 1 1.90 (1.59–2.28) <0.0001
Model 4 1.60 (1.30–1.96) <0.0001
Elevated FPG (≥126 mg/dl)
Model 1 0.95 (0.67–1.36) 0.79
Model 4 0.91 (0.58–1.43) 0.62
Elevated HbA1c (≥6.5%)
Model 1 0.96 (0.68–1.35) 0.82
Model 4* 1.13 (0.71–1.79) 0.61
Model 1: unadjusted.
Model 2: adjusted for age (as a continuous variable), sex, and current smoking
(versus non-smoking).
Model 3: Model 2 plus adjustment for medications (for hypertension, diabetes,
and dyslipidemia), history of stroke or cardiovascular disease, daily alcohol
consumption (versus infrequent/no alcohol consumption), and regular exercise
(≥30 min exercise per session >2 times/week versus infrequent exercise).
Model 4: Model 3 plus overweight (BMI ≥25.0 kg/m2; versus non-overweight,
BMI <25 kg/m2), self-reported skipping breakfast (yes versus no), self-reported
rapid eating (versus normal or slow), eGFR (as a continuous variable), and
elevated FPG (≥126 mg/dl; versus normal FPG, <126 mg/dl).
*Elevated FPG was not adjusted.
eGFR, estimated glomerular filtration rate; FPG, fasting plasma glucose; HbA1c,
hemoglobin A1c.
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healthy behaviors (Table 2, Model 4). However, elevated
fasting plasma glucose and HbA1c (≥6.5%) were not sig-
nificantly associated with ELM. These latter results sug-
gest that ELM is not directly associated with impaired
glucose metabolism, even though plasma glucose levels
were transiently increased after a single late-evening
meal and subsequent breakfast [8]. When the associa-
tions of low serum amylase with self-reported skipping
breakfast and rapid eating were examined, no signifi-
cant association was observed after adjustment for con-
founders listed in Table 2 Model 4 [odds ratio (95% CI),
1.20 (0.94-1.54), P = 0.15 and 0.99 (0.81-1.22), P = 0.96,
respectively].In recent years, unfavorable eating behaviors, such
as rapid eating and skipping breakfast, were reported
to be associated with obesity and abnormal glucose
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http://www.jdmdonline.com/content/12/1/53metabolism [9-14]. The serum amylase level is propor-
tional to the serum level of pancreatic amylase that
leaks from pancreas into the blood [15,16]. Because
pancreatic amylase plays a key role in digestion, the
serum amylase level reflects the state of digestion, par-
ticularly of carbohydrate. Theoretically, low levels of
secreted amylase represent reduced absorption of car-
bohydrate, the predominant energy source in most meals,
and may result in malnutrition and underweight. Un-
expectedly, in our previous studies of asymptomatic
adults, low serum amylase was associated with obesity
and metabolic syndrome [4], which commonly reflect
excess energy intake. Additionally, low levels of sali-
vary amylase, which also contributes to the digestion
of food [17], were observed in diabetic patients [18].
Hyperglycemia after a high-starch load occurred in heal-
thy subjects with low salivary amylase [19]. Therefore, the
associations among ELM, low serum amylase, and over-
weight are not inconsistent with these previous findings.
A plausible explanation for the association is that low
serum amylase may reflect an adaptive process to protect
against prolonged hyperglycemia with regular ELMs and
overweight.
Our study has several limitations. First, the quantity,
type, and precise timing of the evening meal were not
recorded. Second, the questionnaire used to assess eat-
ing behaviors has not been validated. However, the sig-
nificant associations of ELM with other abnormal eating
behaviors, particularly skipping breakfast and rapid eat-
ing, indicate that the simple question about ELM may
be sufficient to suspect ELM and other abnormal eating
behaviors. Nevertheless, the limited data and the design
of the questionnaire could interfere with the observed
associations. Third, other digestive enzymes such as lip-
ase and trypsin were not measured in this study. There-
fore, further studies are needed to confirm the current
findings and to clarify the underlying mechanism and
the causality in more detail.
In conclusion, the current results suggest that ELM is
independently associated with low serum amylase and
common unhealthy behaviors.
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